Dr. Julia May Kwan, MD

Dr. Kwan practices at Seaside Surgical Center Inc in Torrance, California.

Dr. Kwan's NPI, 1225194103, was assigned on December 28, 2006. Dr. Kwan graduated from New York University School of Medicine in 2005. Dr. Kwan's California license number on file is A97170.

Dr. Kwan's primary practice is Seaside Surgical Center Inc, at 4201 Torrance Blvd, Torrance, CA 90503 in Los Angeles County. The practice phone is (310) 540-0144.

Dr. Kwan's primary practice is Seaside Surgical Center Inc in Torrance, California. The medical group on file is Schweiger Dermatology Group, San Pedro. Dmand AI also links Dr. Kwan to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kwan practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Kwan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kwan is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Kwan's licenses on file in 2 states: California and Indiana.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and joint cyst among the conditions Dr. Kwan treats.

CMS data shows 2,408 Medicare services from Dr. Kwan across 11 procedure codes in 2024, for 630 Medicare patients. Medicare paid $134,674 for them. Every service was in an office.

CMS counts 630 Medicare patients who saw Dr. Kwan in 2024. The largest group is 65 to 74, with 313 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kwan's median patient age at 67, with 57% women.

In 2024, Dr. Kwan wrote 1,324 Medicare Part D claims for 539 patients. 92% of them were for generic drugs. CMS names the drug for 1,149 of them, across 28 drugs with 11 or more claims each, at $204,171 in total drug cost. In 2023, CMS named 1,286 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Kwan for performance year 2024, reported individually. Dr. Kwan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kwan as offering telehealth. CMS counts 557 procedures of removal of skin lesions by Dr. Kwan, more than 87% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Kwan, published from 2008 to 2015. 2012 was the busiest year, with 4. The most frequent topics are Laser Therapy, Cicatrix and Blast Injuries. Dr. Kwan has published most often in J Am Acad Dermatol. Dr. Kwan's most frequent co-authors are Nathan S. Uebelhoer, DO, John Paul Trafeli, MD and Elizabeth Kline Satter, MD, MPH, MS.

CMS Open Payments shows 438 general payments to Dr. Kwan from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $2,891.

Dr. Kwan graduated from New York University School of Medicine in 2005. Dr. Kwan is a member of AAD.

Dr. Kwan is in network with 12 carriers, including Aetna, Highmark and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.